Scientists have shed new light on early events in the battle between COVID-19 and the immune system in the nose, a key entry point for the virus.
Dec 7, 2021
0
267
Since the start of the COVID-19 pandemic in December 2019, more than 200 million people have been infected with SARS-CoV-2, resulting in at least 4 million deaths, and probably closer to 7 to 9 million deaths worldwide. Interindividual ...
Aug 20, 2021
1
636
Interferons are potent natural antivirals, rallying other parts of the immune system to defend against viruses. Some clinical trials have tested interferons as a treatment for COVID-19, but results have been mixed, and the ...
Aug 19, 2021
0
215
Researchers at Karolinska Institutet in Sweden have published new findings in the journal Cancer Discovery showing how pharmacological activation of the protein p53 boosts the immune response against tumours. The results ...
Jul 6, 2021
0
7
A study of young men with COVID-19 has revealed a genetic variant linked to disease severity.
Mar 23, 2021
0
13
A study from an international team of researchers from the Helmholtz Diabetes Center at Helmholtz Zentrum Munich, the Institute of Biomedical and Clinical Science at University of Exeter Medical School, and the Department ...
Biomedical engineers at Duke University have demonstrated that human muscle has an innate ability to ward off the damaging effects of chronic inflammation when exercised. The discovery was made possible through the use of ...
Jan 22, 2021
0
704
SARS-CoV-2, the virus that causes COVID-19, blocks the processes of innate immune activation that normally direct the production and/or signaling of type I interferon (IFN-I) by the infected cell and tissues. IFN-I is a key ...
Jan 21, 2021
0
5
Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified the sensor in human lungs that detects SARS-CoV-2 and signals that it's time to mount an antiviral response. The study, published today in Cell ...
Jan 12, 2021
0
18
Hospitalised COVID-19 patients in the UK who received an inhaled form of interferon beta-1a (SNG001) were more likely to recover and less likely to develop severe symptoms than patients who received a placebo, according to ...
Nov 13, 2020
0
1
